You are here: Industry Insights > Drug

News List

AstraZeneca dumps Amgen-partnered drug after midphase fail fiercebiotech
April 28, 2019
AstraZeneca has dropped (PDF) Amgen-partnered autoimmune drug prezalumab from its pipeline. The action follows the failure of the anti-B7RP1 antibody in a midphase Sjöogren’s syndrome trial.
Crystallographic method accelerates drug development europeanpharmaceuticalreview
April 28, 2019
Researchers have developed a novel method that speeds up the process of determining crystal structures of organic salts and significantly reduces the effort required to do so…
Kineret reduces inflammation in stroke patients europeanpharmaceuticalreview
April 28, 2019
An anti-inflammatory drug given to patients in the early stages of a stroke has been shown to reduce harmful inflammation…
Combination immunotherapy improves survival in mouse models of mesothelioma europeanpharmaceuticalreview
April 28, 2019
Combined treatment with two cancer immunotherapy drugs significantly prolonged survival in aggressive cancer malignant mesothelioma…
Pharmaceutical company and its former executives charged for drug trafficking europeanpharmaceuticalreview
April 28, 2019
Pharmaceutical company and its former executives charged for drug trafficking.
Vial switch improves life-saving antiviral drug cphi-online
April 26, 2019
Legacy Pharmaceuticals uses SCHOTT Type I Plus vials to overcome a leaching issue.
FDA awards breakthrough status to La Jolla’s malaria therapy europeanpharmaceuticalreview
April 26, 2019
FDA awards breakthrough status to La Jolla’s malaria therapy.
IL-18 inhibitor drug holds great potential for inflammatory diseases europeanpharmaceuticalreview
April 26, 2019
An international team of researchers has identified the key role that IL-18 protein plays in Still’s disease, making it a prime candidate for IL-18 inhibitor drug that is proving promising in current trials.
Metformin may help with nicotine withdrawal europeanpharmaceuticalreview
April 25, 2019
A drug that has helped millions of people around the world manage their diabetes may also help people ready to kick their nicotine habits…
FDA accepts NDA for ALKS 5461 for major depressive disorder europeanpharmaceuticalreview
April 25, 2019
The FDA has accepted for review the New Drug Application for ALKS 5461, a novel, once-daily, oral investigational medicine for the adjunctive treatment of major depressive disorder …

Previous page 1 2 3 4 5 6 7 8 9 10 ... 49 50 Next page